News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Impliant Ltd. Receives FDA Approval To Begin Pivotal Clinical Trial For Patented TOPS(TM) System


8/23/2006 10:33:24 AM

Impliant, Inc. (www.impliant.com), a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that it has received Conditional Approval from the FDA to enroll patients in a pivotal IDE trial. The patented TOPS™ System is the world's first total posterior motion preservation system to address the leading pathologies of the posterior spinal column.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES